Stockscreener 앱 받기
1.00
4.76%
-0.05
시간 외 거래:
1.05
0.05
+5.00%
전일 마감가:
$1.05
열려 있는:
$1.05
하루 거래량:
129.83K
Relative Volume:
0.98
시가총액:
$19.28M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-17.36%
1개월 성능:
-35.06%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.9995
$1.0809
1주일 범위
$0.9995
$1.27
52주 변동 폭
$0.9995
$6.95
Osr Holdings Inc Stock (OSRH) Company Profile
명칭
Osr Holdings Inc
전화
425-635-7700
주소
10900 NE 4TH STREET, SUITE 2300, BELLEVUE
OSRH을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OSRH
Osr Holdings Inc
|
1.00 | 23.97M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.27 | 123.14B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
550.00 | 60.43B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
324.69 | 42.07B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
572.71 | 34.47B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
290.35 | 27.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Osr Holdings Inc 주식(OSRH)의 최신 뉴스
OSR appoints Andreas Niethammer as Chief Medical Officer of Vaximm AG - MSN
How OSR Holdings Inc. stock performs during market volatilityFree Market Analysis Group - Newser
What makes OSR Holdings Inc. Equity Warrant stock price move sharplyFree Access to Investment Community - Newser
Why OSR Holdings Inc. stock attracts strong analyst attentionTop ROI Selections - Newser
What makes OSR Holdings Inc. stock price move sharplyFree Membership Group - Newser
OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company - Laotian Times
OSR Holdings appoints Andreas Niethammer as CMO of Vaximm AG - Investing.com
Why OSR Holdings Inc. Equity Warrant stock attracts strong analyst attention10x Potential Stocks - Newser
OSR Holdings Appoints Dr. Andreas Niethammer As Chief Medical Officer Of Vaximm AG, An OSR Company - Menafn.com
Cancer Immunotherapy Pioneer Returns to Lead Vaximm's Oral T-Cell Platform Development - Stock Titan
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG - PR Newswire
OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe… - Informazione.it
OSR Holdings plans $50 million security token offering in 2025 By Investing.com - Investing.com Nigeria
OSR Holdings plans $50 million security token offering for second half 2025 By Investing.com - Investing.com South Africa
OSR Holdings announces strategic roadmap for tokenization under Reg D framework - MarketScreener
OSR Holdings plans $50 million security token offering in 2025 - Investing.com
OSR Holdings plans $50 million security token offering for second half 2025 - Investing.com
OSR Holdings independent director Sang Hyun Kim resigns from board By Investing.com - Investing.com India
OSR Holdings, Inc. Announces Resignation of Sang Hyun Kim as A Member of the Board of Directors - MarketScreener
OSR Holdings independent director Sang Hyun Kim resigns from board - Investing.com
OSR Holdings to Explore Development of Blockchain-Based Security Token With BCM Europe - marketscreener.com
OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token - Quantisnow
OSR Holdings shares fall 5.22% intraday despite announcing blockchain-based token development. - AInvest
OSR Holdings, Inc. SEC 10-Q Report - TradingView
OSR Holdings Secures $1.1M Note Purchase Agreement - TipRanks
Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics - PR Newswire
Strategic Moves Drive Stock Gains For OSR, Lianhe Sowell, And Aptevo - Finimize
OSR Holdings Inc’s Market Journey: Closing Weak at 1.53, Down -21.54 - DWinneX
Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology - digitalmore.co
Game-Changing Osteoarthritis Drug Patent: AI-Enhanced Protein Treatment Targets $16B Market - Stock Titan
OSR Holdings (OSRH) Sees Strong Pre-Market Gains - Stocks Telegraph
OSR Holdings enters $80 mln stock purchase agreement with White Lion GBM Innovation Fund - MSN
OSR Holdings Signs $80 Million Stock Deal to Support Brain Cancer Research: Shares Up - marketscreener.com
OSR Signs $80 Mln Stock Purchase Agreement With White Lion GBM Innovation Fund, Stock Up - Nasdaq
OSR Holdings secures $80 million funding option for cancer therapy - Investing.com
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies - digitalmore.co
OSR Holdings Delays Annual Report Filing - TipRanks
Best Biotech Stocks To Follow Today – March 26th - Defense World
3 Penny Stocks to Watch Now, 3/27/25 - TipRanks
Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma - BioSpace
OSR Holdings (OSRH) Sees Stock Surge After Positive Trial Results - Stocks Telegraph
Osr Holdings Inc (OSRH) 재무 분석
Osr Holdings Inc (OSRH)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.64%
0.37%
자본화:
|
볼륨(24시간):